Working… Menu

APG101 in Myelodysplastic Syndrome (APG101 in MDS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01736436
Recruitment Status : Completed
First Posted : November 29, 2012
Last Update Posted : August 24, 2016
Information provided by (Responsible Party):
Apogenix AG ( Apogenix GmbH )

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : December 2015
Actual Study Completion Date : December 2015